bioMérieux Statistics

Total Valuation

bioMérieux has a market cap or net worth of EUR 12.37 billion. The enterprise value is 12.54 billion.

Market Cap	12.37B
Enterprise Value	12.54B

Important Dates

The next estimated earnings date is Thursday, September 5, 2024.

Earnings Date	Sep 5, 2024
Ex-Dividend Date	Jun 7, 2024

Share Statistics

bioMérieux has 118.16 million shares outstanding. The number of shares has increased by 0.12% in one year.

Shares Outstanding	118.16M
Shares Change (YoY)	+0.12%
Shares Change (QoQ)	-0.55%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	18.35%
Float	43.88M

Valuation Ratios

The trailing PE ratio is 34.78 and the forward PE ratio is 25.53. bioMérieux's PEG ratio is 1.89.

PE Ratio	34.78
Forward PE	25.53
PS Ratio	3.37
PB Ratio	3.30
P/FCF Ratio	115.51
PEG Ratio	1.89

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.13, with an EV/FCF ratio of 117.07.

EV / Earnings	35.06
EV / Sales	3.41
EV / EBITDA	14.13
EV / EBIT	22.03
EV / FCF	117.07

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of 13.83.

Current Ratio	2.03
Quick Ratio	1.12
Debt / Equity	13.83
Debt / EBITDA	0.58
Debt / FCF	4.84
Interest Coverage	129.32

Financial Efficiency

Return on equity (ROE) is 8.73% and return on invested capital (ROIC) is 8.45%.

Return on Equity (ROE)	8.73%
Return on Assets (ROA)	6.81%
Return on Capital (ROIC)	8.45%
Revenue Per Employee	268,305
Profits Per Employee	26,110
Employee Count	13,982
Asset Turnover	0.70
Inventory Turnover	1.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.54% in the last 52 weeks. The beta is 0.19, so bioMérieux's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+7.54%
50-Day Moving Average	96.23
200-Day Moving Average	98.39
Relative Strength Index (RSI)	73.05
Average Volume (20 Days)	72,137

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, bioMérieux had revenue of EUR 3.67 billion and earned 357.60 million in profits. Earnings per share was 3.01.

Revenue	3.67B
Gross Profit	2.06B
Operating Income	569.00M
Pretax Income	437.30M
Net Income	357.60M
EBITDA	857.80M
EBIT	569.00M
Earnings Per Share (EPS)	3.01

Balance Sheet

The company has 352.40 million in cash and 518.80 million in debt, giving a net cash position of -166.40 million or -1.41 per share.

Cash & Cash Equivalents	352.40M
Total Debt	518.80M
Net Cash	-166.40M
Net Cash Per Share	-1.41
Equity (Book Value)	3.75B
Book Value Per Share	31.76
Working Capital	1.12B

Cash Flow

In the last 12 months, operating cash flow was 445.40 million and capital expenditures -338.30 million, giving a free cash flow of 107.10 million.

Operating Cash Flow	445.40M
Capital Expenditures	-338.30M
Free Cash Flow	107.10M
FCF Per Share	0.91

Margins

Gross margin is 55.99%, with operating and profit margins of 15.48% and 9.73%.

Gross Margin	55.99%
Operating Margin	15.48%
Pretax Margin	11.90%
Profit Margin	9.73%
EBITDA Margin	23.34%
EBIT Margin	15.48%
FCF Margin	2.91%

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 0.81%.

Dividend Per Share	0.85
Dividend Yield	0.81%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	28.02%
Buyback Yield	-0.12%
Shareholder Yield	0.69%
Earnings Yield	2.87%
FCF Yield	0.87%

Stock Splits

The last stock split was on September 20, 2017. It was a forward split with a ratio of 3.

Last Split Date	Sep 20, 2017
Split Type	Forward
Split Ratio	3